Teva Investigational Site 202 — New York, New York

Teva Investigational Site 202 is a clinical research site located in New York, New York, United States.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Teva Investigational Site 202 has participated in 2 clinical trials.

Therapeutic areas: Depression.

Sponsors: Cephalon.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 202?

Teva Investigational Site 202 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 202 conducted?

Teva Investigational Site 202 has 2 clinical trials on record. Their work covers Depression.

Is Teva Investigational Site 202 accredited by Crixeo Health?

Teva Investigational Site 202 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 202?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.